Recent Trends in Screening and Evaluation Methods of Anticancer Drugs

Journal Title: Indo American Journal of Pharmaceutical Research - Year 2012, Vol 2, Issue 4

Abstract

Cancer is one of the major life threatening diseases worldwide. The available anticancer drugs have distinct mechanisms of action which may vary in their effects on different types of normal and cancer cells. Screening methods are routinely and extensively used to reduce cost and time of drug discovery. The traditional anticancer drug screening methods, including animal experiments and cell-based screening assays. Screening methods for the detection of anticancer activity are of importance in order to find solid tumorspecific agents. The screening and evaluation procedures for the development of anticancer agents indicated that the entire process is a rather difficult task. Presently, active compounds are selected by prescreening and screening against transplanted mouse tumors and human tumor xenografts as well as by the in vitro systems. The US National Cancer Institute (NCI) 60 human tumour cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumours in anticancer drug screening. This screening model give information about the mechanisms of growth inhibition and tumour-cell kill. Recently, its role has changed to that of a service screen supporting the cancer research community. Target-based and cell-based screenings for new anticancer drugs in the molecular targeting period are methods of identifying more selective anticancer drugs. Here I review the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy. Finally, we discuss primary and secondary in vivo evaluation in experimental chemotherapy.

Authors and Affiliations

C. P Rathod, S. C. Dhawale, R. V. Kshirsagar

Keywords

Related Articles

DOSAGE ADJUSTMENTS OF LEVOTHYROXINE IN PATIENTS WITH HYPOTHYROIDISM AND HYPOTHYROIDISM COMPLICATING CORONARY ARTERY DISEASE

Abstract BACK GROUND: Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn't produce enough of thyroid hormone. Women, are more likely to have hypothyroidism, as it is chronic illness, lifelon...

PHARMACOPHORE MODELLING FOR THE DISCOVERY OF SYSTEM XC- ANTIPORTER INHIBITORS

Abstract Cancer is one of the major disorders with increasing rates of morbidity and mortality. Recent drug discovery of anti cancer drug has identified several molecular targets and tried to achieve a goal of therapeuti...

ANTICANCER, ANTIMICROBIAL AND ANTIOXIDANT BIOACTIVE FACTORS DERIVED FROM MARINE FUNGAL ENDOPHYTES; A REVIEW

Abstract The marine-derived fungi has proven to be a very rich source of extremely potent compounds that have demonstrated a number of biologically active compounds with varying degrees of action such as anticancer, anti...

DESIGN AND IN VITRO CHARACTERIZATION OF KETOPROFEN CORE IN CUP PULSATILE TABLETS FOR CHRONOMODULATED DRUG THERAPY.

Abstract The aim of the present investigation is to intend, develop and evaluate a pulsatile drug delivery containing a core-in-cup based system of dry coated tablet of ketoprofen based on chronomodulated approach for ma...

FUNCTIONAL OUTCOME OF FEMORAL NECK FRACTURE TREATED BY BIPOLAR HEMIARTHOPLASTY

Abstract To evaluate outcome of neck fracture of the femur grade III and IV when treated by Bipolar hemiarthoplasty in elderly. Total 42 elderly cases were incorporated in study having neck fracture of femur with grade I...

Download PDF file
  • EP ID EP222175
  • DOI -
  • Views 81
  • Downloads 0

How To Cite

C. P Rathod, S. C. Dhawale, R. V. Kshirsagar (2012). Recent Trends in Screening and Evaluation Methods of Anticancer Drugs. Indo American Journal of Pharmaceutical Research, 2(4), 506-515. https://europub.co.uk/articles/-A-222175